Cell>Point Competitors and Similar CompaniesClear all
Viewpoint Molecular Targeting's competitors and similar companies include Mersana Therapeutics and Seagen.
 Viewpoint Molecular Targeting Viewpoint Molecular Targeting is a radiopharmaceutical company that develops alpha-particle therapy for cancer. |  Mersana Therapeutics Mersana Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugate (ADC) platforms. |  Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer. | |
Founding Date | Founding Date 2008 | Founding Date 2005 | Founding Date 1998 |
Type | Type Subsidiary | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Coralville, US HQ | Locations Cambridge, US HQ | Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more |
Employees | Employees 517% decrease | Employees 11033% increase | Employees 3,25622% increase |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $40.5m (FY, 2024) | Revenue (est.) $2b (FY, 2022) |
Net income | Net income N/A | Net income ($69.2m) (FY, 2024) | Net income ($610.3m) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised $ 300k | Total funding raised $ 219.5m | Total funding raised $ 164m |
For sources of this data, please see the company profile
View Company Profiles
Mersana Therapeutics
HQ
Cambridge, US
Employees
110↑ 33% increase
Mersana Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugate (ADC) platforms.
View companySeagen
HQ
Bothell, US
Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.
View company